top of page
EVENT HIGHLIGHTS

Practical Information on the Use of a Modern Haemostatic Matrix in Urology from the Perspective of a Urological Surgeon

BY:

Dr. Mohsin Roshan

Apr 11, 2025

  • 微信图片_20260414172211_190_280
  • 微信图片_20260414172239_191_280


Moderator

Dr. Yun Sang Chan, Samson

Consultant Urologist, Tuen Mun Hospital, Hong Kong (H.K.)

Member of Urology Specialty Group, Central Coordinating Committee (COC) (Surgery) & the Surgical Outcomes Monitoring & Improvement Programme (SOMIP) Steering Committee

 

Speaker

Professor Marcin Słojewski

Head of Department of Urology and Urological Oncology, University Hospital No 2,

Pomeranian Medical University, Szczecin, Poland

 

There has been a recent and near exponential increase in the use of haemostatic agents and sealants to supplement the rapidly evolving methods in the surgical management of urological patients. To understand the role of the modern haemostatic matrix in the field of Urology, a symposium organised by the Hong Kong Urological Association (HKUA) invited Professor Marcin Słojewski, a renowned Professor in Urology to share his expertise. Prof. Słojewski briefly introduced his role as a surgeon in Szczecin and the evolution of surgery from open surgery to robotic surgery. This was then followed by a brief discussion on bleeding prevention techniques used intraoperatively and the importance of haemodynamic monitoring both intra- and postoperatively. Prof. Słojewski then highlighted the practical application of fibrin sealant patch in Urological surgeries, which included tubeless percutaneous nephrolithotomy (PCNL), robotic partial nephrectomy, and robotic radical prostatectomy. He reiterated that clinical benefits of medicated sponge with human thrombin and human fibrinogen in Urology include enhanced haemostasis, shorter hospital stay, and lower incidence of urine leakage. His final remarks for the symposium was that medicated sponge with human thrombin and human fibrinogen is efficacious and a valuable tool for improving surgical outcomes, in addition to the patient safety.

 

Dr. Chan made an opening remark introducing Prof. Słojewski

 

Prof. Słojewski discussed ways to overcome bleeding risk in urological procedures

 

Application of medicated sponge with human thrombin & human fibrinogen in robotic partial nephrectomy

 

Application of medicated sponge with human thrombin & human fibrinogen in PCNL

 

Organised by:


POPULAR STORY

Uncovering the Tricks of the Silent Thief of Sight

Dr. Roy Lau

Dec 19, 2024

What’s New in Coronary Artery Disease?

Dr. Roy Lau

Aug 20, 2024

Challenges and Strategies for Managing CHB Patients with Co-morbidities

Dr. Roy Lau

Jun 21, 2024

Decoding the Paradox on Impact of Obesity on Cognitive Functioning

Dr. Roy Lau

Jun 20, 2024

Gain Without Pain – Revisiting the Pain Management in Rheumatoid Arthritis

Dr. Roy Lau

Oct 22, 2024

Uncovering the Art of Perfect Matching – A Review on Precision Oncology

Dr. Roy Lau

Feb 17, 2025

The Earlier The Better: The New Frontiers of Lipid Research for Cardiovascular Disease Prevention

Dr. Feng Xue

Feb 11, 2026

What Should We Know About Anxiety Disorder?

Dr. Roy Lau

Apr 11, 2025

Rheumatology in 2025: Breakthroughs, Technologies, and the Future of Care

Dr. Feng Xue

Oct 24, 2025

Rare Genomic Targets in NSCLC: 2025 Breakthroughs in Precision Therapy and Future Directions

Dr. Feng Xue

Dec 19, 2025

Breaking the Pathologic Combo of CVD and T2DM – Now and Then

Dr. Roy Lau

Aug 14, 2025

No More Itch – Uncovering Urticaria and Its Clinical Management

Dr. Roy Lau

Jun 13, 2025

bottom of page